The role of URO17™ biomarker to enhance diagnosis of urothelial cancer in new hematuria patients—First European Data

Author:

Vasdev Nikhil12ORCID,Hampson Alexander1ORCID,Agarwal Samita3,Swamy Rajiv3,Chilvers Michael4,Hampson Amy1,Jahanfard Sholeh5,Kim Nam5

Affiliation:

1. Hertfordshire and Bedfordshire Urological Cancer Centre Department of Urology Lister Hospital Stevenage UK

2. School of Life and Medical Sciences University of Hertfordshire Hatfield UK

3. Department of Pathology Lister Hospital Stevenage UK

4. Department of Anaesthetics Lister Hospital Stevenage UK

5. KDx Diagnostics Inc Campbell CA USA

Publisher

Wiley

Subject

Religious studies,Cultural Studies

Reference34 articles.

1. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018

2. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

3. Non-visible versus visible haematuria and bladder cancer risk: a study of electronic records in primary care

4. Cancer facts & figures 2020;American Cancer Society;American Cancer Society,2020

5. Urinary biomarkers in bladder cancer: a review of current landscape and future applications;Ng K;Urologic Oncology: Seminars and Origional Investigtions,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3